ZOPTARELIN DOXORUBICIN
UNII 27844X2J29

Substance Identification & Data

This profile provides standardized clinical and technical data for Zoptarelin Doxorubicin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 27844X2J29.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 139570-93-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
27844X2J29
CAS Registry Number
139570-93-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ZOPTARELIN DOXORUBICIN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C91H117N19O26
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
OOUACICUAVTCEC-LZHWUUGESA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
INN ID
9507
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
EF-28
Identifier assigned by the United States Adopted Names Council.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c12c(O)c3C[C@@](C[C@H](O[C@@]4([H])C[C@H](N)[C@H](O)[C@H](C)O4)c3c(O)c2C(c5c(OC)cccc5C1=O)=O)(O)C(COC(CCCC(NCCCC[C@@H](NC(=O)[C@H](Cc6ccc(O)cc6)NC([C@@H](NC(=O)[C@H](Cc7c[nH]c8ccccc87)NC([C@H](Cc9cnc[nH]9)NC([C@@H]%10CCC(N%10)=O)=O)=O)CO)=O)C(=O)N[C@@H](CC(C)C)C(N[C@@H](CCCNC(=N)N)C(N%11[C@@H](CCC%11)C(NCC(N)=O)=O)=O)=O)=O)=O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zoptarelin Doxorubicin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZOPTARELIN DOXORUBICIN

Common Names & Synonyms

ZOPTARELIN DOXORUBICIN [INN]
ZOPTARELIN DOXORUBICIN [USAN]
ZOPTARELIN DOXORUBICIN [WHO-DD]

Systematic Nomenclature

(6-D-LYSINE)HUMAN GONADOLIBERIN-1 (LHRH) AND DOXORUBICIN COVALENTLY LINKED TOGETHER WITH GLUTARIC ACID: 5-OXO-L-PROLYL-L-HISTIDYL-L-TRYPTOPHYL-L-SERYL-L-TYROSYL-N6-(5-(2-((2S,4S)-4-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-1,2,3,4,6,11-HEXAHYDROTETRACEN-2-YL)-2-OXOETHOXY)-5-OXOPENTANOYL)-D-LYSINE-L-LEUCYL-L-ARGINYL-L-PROLYLGLYCINAMIDE
LUTEINIZING HORMONE-RELEASING FACTOR (PIG), 6-(N6-(5-(2-(4-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-1,2,3,4,6,11-HEXAHYDRO-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-2-NAPHTHACENYL)-2-OXOETHOXY)-1,5-DIOXOPENTYL)-D-LYSINE)-, (2S-CIS)-
LUTEINIZING HORMONE-RELEASING FACTOR (SWINE), 6-(N6-(5-(2-((2S,4S)-4-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-1,2,3,4,6,11-HEXAHYDRO-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-2-NAPHTHACENYL)-2-OXOETHOXY)-1,5-DIOXOPENTYL)-D-LYSINE)-